Supreme Court Keeps Abortion-Pill Access Open as Mifepristone Case Winds Through Court

The Supreme Court on Monday extended a short-term stay allowing patients to continue obtaining the abortion pill mifepristone via telehealth visits and mail through Thursday at 5 p.m. ET, while it weighs an emergency appeal. The extension preserves access after the 5th Circuit had ordered in-person visits, a ruling that sparked chaos for providers. The case ties FDA policy on mifepristone to the broader Dobbs era of abortion politics, with Louisiana challenging the FDA and both Danco Laboratories and GenBioPro filing emergency appeals.